This is a preview of subscription content, log in to check access.
We’re sorry, something doesn't seem to be working properly.
Please try refreshing the page. If that doesn't work, please contact support so we can address the problem.
Boulant T, et al. A 2.5-Year Within-Patient Evolution of Pseudomonas aeruginosa Isolates with in Vivo Acquisition of Ceftolozane-Tazobactam and Ceftazidime-Avibactam Resistance upon Treatment. Antimicrobial Agents and Chemotherapy 63: e01637-19, No. 12, Dec 2019. Available from: URL: http://doi.org/10.1128/AAC.01637-19